Stay updated on Combination Immunotherapy in SCLC Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.

Latest updates to the Combination Immunotherapy in SCLC Clinical Trial page
- Check5 days agoChange DetectedA site-wide notice about government funding and the operating status, along with a page revision label (v3.4.1), were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoChange DetectedThe page adds a 'Show glossary' control and updates footer/versioning text, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. It also includes minor casing adjustments like 'No FEAR Act Data' vs 'No FEAR Act data' and the removal of older phrasing 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check47 days agoChange DetectedA dedicated Locations section was added, listing Florida as a study site. This updates where the trial is conducted and available for enrollment.SummaryDifference0.2%

- Check69 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedAdministrative page revision updated from v3.2.0 to v3.3.1; this change does not alter study content, eligibility criteria, outcomes, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded sections listing the Moffitt Cancer Center Clinical Trials website, the H. Lee Moffitt Cancer Center and Research Institute, and a 'Helpful Links Provided by' area. Removed the government funding status notice regarding NIH/agency operating status.SummaryDifference0.5%

Stay in the know with updates to Combination Immunotherapy in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.